drugset / Trial / NCT07704697
Assess Sacubitril/Allisartan and Amlodipine in Patients With Essential Hypertension Uncontrolled With Sacubitril/Allisartan
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The main objective of the study will be to assess the efficacy and safety of Sacubitril/Allisartan (240mg) and Amlodipine (5mg) in patients with essential hypertension uncontrolled after 4-week treatment with Sacubitril/Allisartan (240mg).
Timeline
- Start
- 2024-11-23
- Primary completion
- 2025-11-10
- Completion
- 2025-11-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | 5 mg | — |
| Background | Sacubitril | Small molecule | 240 mg | — |